Drugs for Rare Diseases and the Role of Private Payers
How Canada's fragmented coverage system reaches — or fails to reach — patients with rare diseases.
Latest analysis
MORSE Insights · Vol. 1
Canadian market access, decoded.
MORSE Insights is where our team shares deeper perspectives on the forces shaping pharmaceutical market access in Canada. Drawing on decades of experience navigating the reimbursement landscape, we go beyond the headlines to examine what is changing, why it matters, and what it means for companies bringing therapies to Canadian patients.